drug delivery is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions.
The report takes the reader through a comprehensive review Injectable
Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Injectable
Drug Delivery partnering deals.
Some of the drugs that are commonly administered by injectable
drug delivery include analgesics, antibiotics, immunosuppressive agents, antihypertensive agents, vasodilators, chemotherapeutic agents and antiarrhythmic drugs.
Brent Saunders, CEO and president of Actavis, said, 'Over the last several years, we have been steadily growing our generic specialty injectable
business around the world, marketing products in more than 50 countries.
drug product demand by indication and therapy to 2018
Two-thirds had ever used oral contraceptives, and roughly one in 10 women had used the injectable
Explores clinical applications of injectable
biomaterials, including drug delivery, tissue engineering, orthopaedic applications and injectable
materials for gene delivery systems
Commenting on the report, an analyst from TechNavio's Healthcare team said, Although the Americas and the EMEA region are the main revenue generators in the Global Facial Injectable
market, the majority of the global vendors are focusing on the APAC region.
This report provides a comprehensive assessment and analysis of the current market for viscoaugmentation and viscosupplementation products and shows how research and development has expanded product choice and diversity among the relatively limited injectable
medical devices that are approved.
ArteFill is the first and only FDA-approved non-resorbable injectable
dermal filler for the correction of wrinkles known as smile lines or nasolabial folds.
Nasdaq: ARTE), a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable
products for men and women, today announced 5-year safety and efficacy data for ArteFill[R], the Company's non-resorbable FDA-approved injectable
Alkermes currently has two commercial products: RISPERDAL([R]) CONSTA([R])[(risperidone) long-acting injection], the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag (Janssen), a wholly owned division of Johnson & Johnson; and VIVITROL([R]) (naltrexone for extended-release injectable
suspension) the first and only once-monthly injectable
medication approved for the treatment of alcohol dependence and marketed in the U.